A team of researchers disprove a decades-old dogma. The result? The first ever FDA-approved drug for primary-progressive multiple sclerosis.
A team of researchers disprove a decades-old dogma. The result? The first ever FDA-approved drug for primary-progressive multiple sclerosis.